Mamoru Nukatsuka
- Molecular Biology
- Oncology top 10%
- Inorganic Chemistry top 5%
- Pulmonary and Respiratory Medicine
- Cancer Research
- Co-authors
- Jun‐ichi KawadaJUN KAWADAHiromu SakuraiMasakazu FukushimaFumio NakagawaH. SakuraïMuroto SofueTeiji Takechi
- Topics
- Colorectal Cancer Treatments and Studies (11 papers)Gastric Cancer Management and Outcomes (6 papers)Cancer, Hypoxia, and Metabolism (6 papers)
- Partner nations
- JapanCanadaUnited States
In The Last Decade
Mamoru Nukatsuka
43 papers receiving 874 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 287
- Oncology 270
- Inorganic Chemistry 235
- Pulmonary and Respiratory Medicine 122
- Cancer Research 103
Countries citing papers authored by Mamoru Nukatsuka
This map shows the geographic impact of Mamoru Nukatsuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mamoru Nukatsuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mamoru Nukatsuka more than expected).
Fields of papers citing papers by Mamoru Nukatsuka
This network shows the impact of papers produced by Mamoru Nukatsuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mamoru Nukatsuka. The network helps show where Mamoru Nukatsuka may publish in the future.
Co-authorship network of co-authors of Mamoru Nukatsuka
This figure shows the co-authorship network connecting the top 25 collaborators of Mamoru Nukatsuka. A scholar is included among the top collaborators of Mamoru Nukatsuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mamoru Nukatsuka. Mamoru Nukatsuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 5 | |
| 3 | 6 | |
| 4 | 8 | |
| 5 | 8 | |
| 6 | 13 | |
| 7 | 1 | |
| 8 | 11 | |
| 9 | A new combination chemotherapy based on oral fluoropyrimidine, TS-1 combined with oxaliplatin is highly effective against colorectal cancer in vivo | 1 |
| 10 | 20 | |
| 11 | 39 | |
| 12 | 13 | |
| 13 | 8 | |
| 14 | 11 | |
| 15 | Cytotoxic quinolines (part 2). Azolylalkylamino and-thio quinolines. | 4 |
| 16 | 5 | |
| 17 | 6 | |
| 18 | 63 | |
| 19 | 2 | |
| 20 | 9 |
About Mamoru Nukatsuka
Mamoru Nukatsuka is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 908 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (11 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Inorganic Chemistry (235 citations), Oncology (270 citations) and Cancer Research (103 citations). Mamoru Nukatsuka has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Jun‐ichi Kawada, JUN KAWADA, Hiromu Sakurai, Masakazu Fukushima, Fumio Nakagawa, H. Sakuraï, Muroto Sofue, Teiji Takechi, Mikio Nishida and M. Nishida. Their work appears in journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.